These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Causes and factors of development of drug resistance in pulmonary tuberculosis]. Nechaeva OB; Skachkova EI Probl Tuberk Bolezn Legk; 2003; (9):6-9. PubMed ID: 14598516 [TBL] [Abstract][Full Text] [Related]
45. [Chemotherapy effectiveness using tuberculin, prodigiozan and pyrogenal in destructive pulmonary tuberculosis]. Insanov AV Probl Tuberk; 1981 Oct; (10):31-2. PubMed ID: 7312847 [No Abstract] [Full Text] [Related]
46. [Combined effects of drugs]. Kudrin AN Sov Med; 1982; (4):89-94. PubMed ID: 7048562 [No Abstract] [Full Text] [Related]
47. [Addition in drug combination (author's transl)]. Jin ZJ Zhongguo Yao Li Xue Bao; 1980 Dec; 1(2):70-6. PubMed ID: 6461187 [No Abstract] [Full Text] [Related]
48. [Two new formulae for evaluating the effectiveness of drug combinations and the revision of Bürgi's and Jin's modified Bürgi's formulae]. Zhou YY; Wang HY; Tang ZG; Ma DL Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):217-21. PubMed ID: 6242209 [No Abstract] [Full Text] [Related]
49. Quantitation of increase in maximum drug response caused by potentiating agents. Pöch G Arzneimittelforschung; 1980; 30(8):1310-1. PubMed ID: 7192149 [TBL] [Abstract][Full Text] [Related]
51. [Expected and unexpected reactions in drug therapy]. Ariëns EJ Folia Med Neerl; 1968; 11(3):85-94. PubMed ID: 5707013 [No Abstract] [Full Text] [Related]
52. Toxic reactions due to drug synergism and antagonism. Grosshandler SL; Hanschel EO; Kampine JP Anesth Analg; 1968; 47(4):345-9. PubMed ID: 5690523 [No Abstract] [Full Text] [Related]